Adicet Bio Inc logo

Adicet Bio Inc

$ 19.66 -0.53 (-2.63%) 10:08 PM EST
P/E:
At Loss
P/B:
2.65
Market Cap:
$ 842.46M
Enterprise V:
$ 604.21M
Volume:
567.37K
Avg Vol (2M):
535.40K
Also Trade In:
Volume:
567.37K
Market Cap $:
842.46M
PE Ratio:
At Loss
Avg Vol (2-Month):
535.40K
Enterprise Value $:
604.21M
PB Ratio:
2.65
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
Name Current Vs Industry Vs History
Cash-To-Debt 13.02
Equity-to-Asset 0.9
Debt-to-Equity 0.07
Debt-to-EBITDA -0.4
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 13.82
Distress
Grey
Safe
Beneish M-Score -1.6
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 67.41
9-Day RSI 62
14-Day RSI 59.3
6-1 Month Momentum % 45.76
12-1 Month Momentum % 31.69

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 16.59
Quick Ratio 16.59
Cash Ratio 16.41
Days Sales Outstanding 1.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -26.6

Financials (Next Earnings Date:2023-03-15 Est.)

ACET's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:ACET

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 30.458
EPS (TTM) ($) -1.46
Beta 0
Volatility % 101.43
14-Day RSI 59.3
14-Day ATR ($) 1.251858
20-Day SMA ($) 18.6835
12-1 Month Momentum % 31.69
52-Week Range ($) 9.88 - 21.87
Shares Outstanding (Mil) 42.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Adicet Bio Inc Filings

Document Form Filing Date
No Filing Data

Adicet Bio Inc Analysis

Share your research

Headlines

See More
No news.